Sarepta Therapeutics Inc
(NAS:SRPT)
$
115.5109
1.1909 (1.04%)
Market Cap: 11.03 Bil
Enterprise Value: 11.23 Bil
PE Ratio: 75.01
PB Ratio: 9.03
GF Score: 85/100 
Sarepta Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript
Jun 16, 2021 / 02:30PM GMT
Release Date Price:
$82.14
(-1.20%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Okay. Good morning, everybody. Thanks for joining us at the Bank of America Virtual Napa Conference. It's my pleasure this morning to have with us Sarepta as our next presenting company. For the next 50 minutes, I have the pleasure of speaking with Doug Ingram, who is President and Chief Executive Officer; as well as Ian Estepan, who is CFO. Doug and Ian, good morning. Thanks for joining us.
Douglas S. Ingram
Sarepta Therapeutics, Inc. - President, CEO & Director
Thank you for having us, Tazeen.
Ian Michael Estepan
Sarepta Therapeutics, Inc. - Executive VP & CFO
Thank you.
Tazeen Ahmad
BofA Securities, Research Division - VP
So we do hope to be back to Napa next year, but we're happy that you joined us virtually from Boston today.
Questions & Answers
Tazeen Ahmad
BofA Securities, Research Division - VP
So maybe for those that are listening, can you
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers